Medpace (MEDP) Insider Trading & Ownership $463.64 +10.30 (+2.27%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$463.38 -0.26 (-0.06%) As of 08/22/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Medpace (NASDAQ:MEDP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$652.22Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$52.31M Get MEDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Medpace stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MEDP Insider Buying and Selling by Quarter Medpace Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/19/2025Cornelius P Mccarthy IIIDirectorSell1,662$465.04$772,896.48 7/28/2025August J TroendleCEOSell48,487$451.69$21,901,093.03 7/28/2025Stephen P EwaldGeneral CounselSell3,000$450.00$1,350,000.00 7/28/2025Susan E BurwigVPSell7,500$450.14$3,376,050.00 7/24/2025Jesse J GeigerPresidentSell41,801$453.11$18,940,451.11 7/24/2025Kevin M BradyCFOSell12,000$454.23$5,450,760.00 7/24/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Sell$455.68$1,001 - $15,0007/22/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$477.73$1,001 - $15,0004/24/2025Fred B Davenport JrDirectorSell1,712$301.82$516,715.84 2/27/2025Stephen P EwaldGeneral CounselBuy2$326.11$652.22 (Data available from 1/1/2013 forward) MEDP Insider Trading Activity - Frequently Asked Questions Who is on Medpace's Insider Roster? The list of insiders at Medpace includes Ashley M Keating, August J Troendle, Cornelius P Mccarthy III, Fred B Davenport Jr, Jesse J Geiger, Kevin M Brady, Medpace Investors, Llc, Robert O Kraft, Stephen P Ewald, and Susan E Burwig. Learn more on insiders at MEDP. What percentage of Medpace stock is owned by insiders? 20.30% of Medpace stock is owned by insiders. Learn more on MEDP's insider holdings. Which Medpace insiders have been buying company stock? The following insider purchased MEDP shares in the last 24 months: Stephen P Ewald ($652.22). How much insider buying is happening at Medpace? Insiders have purchased a total of 2 MEDP shares in the last 24 months for a total of $652.22 bought. Which Medpace insiders have been selling company stock? The following insiders have sold MEDP shares in the last 24 months: Ashley M Keating ($102,467.50), August J Troendle ($162,893,510.21), Cornelius P Mccarthy III ($772,896.48), Fred B Davenport Jr ($516,715.84), Jesse J Geiger ($18,940,451.11), Kevin M Brady ($5,450,760.00), Medpace Investors, Llc ($85,053,605.12), Stephen P Ewald ($1,350,000.00), and Susan E Burwig ($6,577,578.65). How much insider selling is happening at Medpace? Insiders have sold a total of 863,586 Medpace shares in the last 24 months for a total of $281,657,984.91 sold. Which members of congress are trading Medpace? Lisa C. McClain (R-MI) has bought shares of Medpace in the last year totaling $8,000. Gilbert Ray Cisneros, Jr. (D-CA) and Robert Bresnahan, Jr. (R-PA) have sold shares totaling $16,000. Medpace Key ExecutivesDr. August James Troendle M.D. (Age 68)Chairman & CEO Compensation: $1.65MMr. Jesse J. Geiger BBA (Age 50)CPA, President Compensation: $945.08k1 recent tradesMr. Kevin M. Brady (Age 49)CFO & Treasurer Compensation: $690.48k1 recent tradesMs. Susan E. Burwig BSN (Age 61)MA, Executive Vice President of Operations Compensation: $1.12M1 recent tradesMr. Stephen P. Ewald J.D. (Age 55)Chief Compliance Officer, General Counsel & Corporate Secretary Compensation: $914.64k2 recent tradesBrandon EbkenChief Information OfficerMs. Lauren MorrisAssociate Director of Investors RelationsMr. Todd MeyersVice President of Business Development & MarketingJohn T. Wynne MBASenior Vice President of Commercial Operations & Clinical Pharmacology UnitMr. Reinilde Heyrman M.D. (Age 63)Chief Medical Officer of Medical Department More Insider Trading Tools from MarketBeat Related Companies ICLR Insider Transactions EHC Insider Transactions ELV Insider Transactions HIMS Insider Transactions IQV Insider Transactions WCN Insider Transactions RDDT Insider Transactions TCOM Insider Transactions TOST Insider Transactions RBA Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NASDAQ:MEDP) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access